Statin therapy--Part II: Clinical considerations for cardiovascular disease.
3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, commonly known as statins, are the medical treatment of choice for hypercholesterolemia. In addition to achieving a therapeutic decrease in serum cholesterol levels, statin therapy appears to promote pleiotropic effects that are independent of changes in serum cholesterol. These cholesterol lowering and pleiotropic effects are beneficial not only for the coronary circulation, but for the myocardium and peripheral arterial system as well. Patients receiving statin therapy must be carefully monitored, however, as statins potentially have harmful side effects and drug interactions. This article is part II of a 2-part review, and it focuses on the clinical aspects of statin therapy in cardiovascular disease.
Duke Scholars
Published In
DOI
EISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- Treatment Outcome
- Risk Assessment
- Peripheral Arterial Disease
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Humans
- Heart Failure
- Drug Interactions
- Coronary Artery Disease
- Cerebrovascular Disorders
- Cardiovascular System & Hematology
Citation
Published In
DOI
EISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- Treatment Outcome
- Risk Assessment
- Peripheral Arterial Disease
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Humans
- Heart Failure
- Drug Interactions
- Coronary Artery Disease
- Cerebrovascular Disorders
- Cardiovascular System & Hematology